Schroeter, L.;Meissner, V.;Koehn, F.;Kron, M.;Schulwitz, H.;Arsov, C.;Hadaschik, B.;Imkamp, F.;Zitzmann, M.;Gschwend, J.;Herkommer, K..Association of low sexual desire with current sexual behavior, self-concept as well as comorbidities and lifestyle factors.BJU Int.2019.123 Suppl 3.39-39

Mayer, Marcel;Selig, Katharina;Tuettelmann, Frank;Dinkel, Andreas;Gschwend, Juergen E.;Herkommer, Kathleen.Interest in, willingness-to-pay for and willingness-to-recommend genetic testing for prostate cancer among affected men after radical prostatectomy.Fam Cancer.2019.18.2.221-230

Maurer, Tobias;Kroenke, Markus;Wurzer, Alexander;Ulbrich, Lena;Jooss, Lena;Horn, Thomas;Haller, Bernhard;Weber, Wolfgang;Wester, Hans-Juergen;Eiber, Matthias.18F-RHPSMA7 POSITRON EMISSION TOMOGRAPHY FOR THE DETECTION OF BIOCHEMICAL RECURRENCE OF PROSTATE CANCER FOLLOWING RADICAL PROSTATECTOMY.J Urol.2019.201 Suppl S.4.E114-E115

Herkommer, Kathleen;Meissner, Valentin Henri;Ertilav, Zuebeyde;Kron, Martina;Schulwitz, Helga;Albers, Peter;Arsov, Christian;Kuczyk, Markus;Imkamp, Florian;Hohenfellner, Markus;Hadaschik, Boris;Gschwend, Juergen Erich.ASSOCIATION OF COMMON MEDICATION WITH PROSTATE-SPECIFIC ANTIGEN LEVEL IN 45-YEAR-OLD GERMAN MEN: RESULTS OF THE PROBASE TRIAL.J Urol.2019.201 Suppl S.4.E652-E652

Maurer, T.;Hadaschik, B.;Budaeus, L.;Steuber, T.;Salomon, G.;Horn, T.;Herrmann, K.;Weber, M.;Giesel, F. L.;Berliner, C.;Eiber, M..PSA increase after definitive treatment.Urologe A.2019.58.5.569-582

Schineis, J.;Kron, M.;Schiele, S.;Dinkel, A.;Arsov, C.;Hadaschik, B.;Imkamp, F.;Gschwend, J.;Herkommer, K..MORE NEGATIVE SEXUAL SELF-CONCEPT IN MEN WITH ERECTILE DYSFUNCTION, PREMATURE EJACULATION OR LOW SEXUAL DESIRE.J Sex Med.2019.16 Suppl 2.5.S66-S66

Hahn, Noah M.;Chang, Sam S.;Meng, Maxwell;Shore, Neal D.;Konety, Badrinath R.;Steinberg, Gary D.;Gschwend, Juergen E.;Nishiyama, Hiroyuki;Redorta, Juan Palou;Taylor, John Arthur;Elegbe, Ayanbola;Lambert, Alexandre;Zhu, Li;Ishii, Yuko;Maeda, Toshiki;Raybold, Bradley;Grossfeld, Gary;Fischer, Bruce S.;Rutstein, Mark;Witjes, Alfred.A phase II, randomized study of nivolumab (nivo) or nivo plus BMS-986205 with or without intravesical Bacillus Calmette-Guerin (BCG) in BCG-unresponsive, high-risk, non-muscle invasive bladder cancer (NMIBC): CheckMate 9UT..J Clin Oncol.2019.37 Suppl S.7

Massard, Christophe;Retz, Margitta;Hammerer, Peter;Quevedo, Fernando;Fong, Peter C. C.;Berry, William R.;Gurney, Howard;Piulats, Josep M.;Joshua, Anthony;Linch, Mark David;Kolinsky, Michael;Romano, Emanuela;Sridhar, Srikala S.;Conter, Henry Jacob;Augustin, Marinela;Wu, Haiyan;Schloss, Charles;Poehlein, Christian Heinrich;Yu, Evan Y..Keynote-365 cohort b: Pembrolizumab (pembro) plus docetaxel and prednisone in abiraterone (abi) or enzalutamide (enza)-pretreated patients (pts) with metastatic castrate resistant prostate cancer (mCRPC)..J Clin Oncol.2019.37 Suppl S.7

Yu, Evan Y.;Massard, Christophe;Retz, Margitta;Tafreshi, Ali;Carles Galceran, Joan;Hammerer, Peter;Fong, Peter C. C.;Shore, Neal D.;Joshua, Anthony;Linch, Mark David;Gurney, Howard;Romano, Emanuela;Augustin, Marinela;Piulats, Josep M.;Wu, Haiyan;Schloss, Charles;Poehlein, Christian Heinrich;De Bono, Johann S..Keynote-365 cohort a: Pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC)..J Clin Oncol.2019.37 Suppl S.7

Miller, Kurt;Bergmann, Lothar;Doehn, Christian;Gschwend, Jürgen E;Kuczyk, Markus A.[Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma]..Aktuelle Urol.2019